- ASSISTANT PROFESSOR Health Evidence and Policy
BA, Williams College
MS, Columbia University
Biostatistics, Theory and Methods
Ph.D. with Distinction, Columbia University
I am a recent graduate of a Columbia’s Biostatistics Ph.D. program with a specialization in novel designs for clinical trials. I plan to pursue methods-oriented research, emphasizing early phase drug and device development.
Other topics that appeal to me are designed observational studies and causal inference.Previous applied projects of mine have been in Orthopedics, Coagulopathy, and Obesity.
2012 - 2012
Cotton A, Freeman D, Gnepp A, Ng T, Spivack J, Yoder C. The Isoperimetric Problem on Some Singular Surfaces. Journal of the. Australian, Mathematical Society 2005; 78: 167-197.
Silva A, Wang J, Peirson R, Wang Z, Spivack J, Allison D, Heymsfeld S, Sardinha L, Heshka S. Extracellular Water Across the Adult Lifespan: Reference Values for Adults. Physiological measurement 2007; 28(5): 489-502.
Vitale M, Van Beek C, Spivack J, Cheng B, Geller J. Pharmacologic Reversal of Warfarin-Associated Coagulopathy in Geriatric Patients with Hip Fractures A Retrospective Study of Thromboembolic Events, Postoperative Complications, and Time to Surgery. Geriatric Orthopaedic Surgery & Rehabilitation 2011; 2(4): 128-134.
Spivack J. The Limb-Leaf Design: A New Way to Explore the Dose Response Curve in Adaptive Seamless Phase II/III Trials. Ph.D. Dissertation, Columbia University 2011;.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Spivack did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Icahn Medical Institute Floor 3rd Floor Room L3-53
1425 Madison Avenue
New York, NY 10029